May 6, 2008 (Washington) — A new, once-a-month shot shows promise for the treatment of schizophrenia.
The new drug is called paliperidone palmitate. It’s an injectable form of the second-generation, or “atypical,” antipsychotic medication Invega.
A study pitting injectable paliperidone palmitate against placebo was halted early because of its clear benefit in preventing relapses, says David Hough, [...]
Entries from March 2009
Injectable Drug Could Make Treatment Plan Easier to Follow
March 4th, 2009 · No Comments
Tags: Administrator